| Marvin Scotvold, | |
|
602 E Nob Hill Blvd, Yakima, WA 98901-3534 | |
| (509) 248-3334 | |
| (509) 453-6144 |
| Full Name | Marvin Scotvold |
|---|---|
| Gender | Male |
| Speciality | Dermatology |
| Experience | 61 Years |
| Location | 602 E Nob Hill Blvd, Yakima, Washington |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1528154713 | NPI | - | NPPES |
| 4963 | Other | GROUP HEALTH | |
| 8372302 | Other | WA | CHPW |
| 44501 | Other | WA | L & I |
| 9390SC | Other | WA | REGENCE |
| 8372302 | Medicaid | WA | |
| 911019392 | Other | COMMERCIAL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | MD00009476 (Washington) | Secondary |
| 207N00000X | Dermatology | MD00009476 (Washington) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Yakima Valley Farm Workers Clinic | 4385541986 | 198 |
News Archive
ThromboGenics NV, a biopharmaceutical company focused on developing innovative ophthalmic medicines, today announced that the U.S. Food and Drug Administration (FDA) has informed the Company that it has officially accepted the filing of the Biologics License Application for ocriplasmin intravitreal injection, 2.5 mg/ml and granted it Priority Review.
Durata Therapeutics today announced that it has completed its target enrollment for DISCOVER 1 ("Dalbavancin for Infections of the Skin COmpared to Vancomycin at an Early Response"), one of two ongoing, global, Phase 3 clinical trials of Durata's lead product candidate, dalbavancin, under investigation for the treatment of acute bacterial skin and skin structure infections (abSSSI).
Cardiovascular complications and hypoglycemia (low blood sugar) were common nonfatal complications in adults 60 years of age and older with diabetes, according to a study published by JAMA Internal Medicine, a JAMA Network publication.
In Florida carpenter ant colonies, distinct worker castes called minors and majors exhibit pronounced differences in social behavior throughout their lives. In a new study published today in Science, a multi-institution team anchored at University of Pennsylvania found that these caste-specific behaviors are not set in stone.
› Verified 7 days ago
| Entity Name | Yakima Valley Farm Workers Clinic |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1295788602 PECOS PAC ID: 4385541986 Enrollment ID: O20040211000663 |
News Archive
ThromboGenics NV, a biopharmaceutical company focused on developing innovative ophthalmic medicines, today announced that the U.S. Food and Drug Administration (FDA) has informed the Company that it has officially accepted the filing of the Biologics License Application for ocriplasmin intravitreal injection, 2.5 mg/ml and granted it Priority Review.
Durata Therapeutics today announced that it has completed its target enrollment for DISCOVER 1 ("Dalbavancin for Infections of the Skin COmpared to Vancomycin at an Early Response"), one of two ongoing, global, Phase 3 clinical trials of Durata's lead product candidate, dalbavancin, under investigation for the treatment of acute bacterial skin and skin structure infections (abSSSI).
Cardiovascular complications and hypoglycemia (low blood sugar) were common nonfatal complications in adults 60 years of age and older with diabetes, according to a study published by JAMA Internal Medicine, a JAMA Network publication.
In Florida carpenter ant colonies, distinct worker castes called minors and majors exhibit pronounced differences in social behavior throughout their lives. In a new study published today in Science, a multi-institution team anchored at University of Pennsylvania found that these caste-specific behaviors are not set in stone.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Marvin Scotvold, 602 E Nob Hill Blvd, Yakima, WA 98901-3534 Ph: (509) 248-3334 | Marvin Scotvold, 602 E Nob Hill Blvd, Yakima, WA 98901-3534 Ph: (509) 248-3334 |
News Archive
ThromboGenics NV, a biopharmaceutical company focused on developing innovative ophthalmic medicines, today announced that the U.S. Food and Drug Administration (FDA) has informed the Company that it has officially accepted the filing of the Biologics License Application for ocriplasmin intravitreal injection, 2.5 mg/ml and granted it Priority Review.
Durata Therapeutics today announced that it has completed its target enrollment for DISCOVER 1 ("Dalbavancin for Infections of the Skin COmpared to Vancomycin at an Early Response"), one of two ongoing, global, Phase 3 clinical trials of Durata's lead product candidate, dalbavancin, under investigation for the treatment of acute bacterial skin and skin structure infections (abSSSI).
Cardiovascular complications and hypoglycemia (low blood sugar) were common nonfatal complications in adults 60 years of age and older with diabetes, according to a study published by JAMA Internal Medicine, a JAMA Network publication.
In Florida carpenter ant colonies, distinct worker castes called minors and majors exhibit pronounced differences in social behavior throughout their lives. In a new study published today in Science, a multi-institution team anchored at University of Pennsylvania found that these caste-specific behaviors are not set in stone.
› Verified 7 days ago
Mr. Kirk Torgle Ecklund, MD Dermatology Medicare: May Accept Medicare Assignments Practice Location: 3911 Castlevale Rd, Ste 301, Yakima, WA 98902 Phone: 509-965-1714 Fax: 509-965-1714 | |
Dr. Donald Michael Pehlke, MD Dermatology Medicare: Not Enrolled in Medicare Practice Location: 1111 W Spruce, Suite 24, Yakima, WA 98902 Phone: 509-575-6888 Fax: 509-575-0455 | |
Dr. Benjamin Blaine Jones, M.D. Dermatology Medicare: May Accept Medicare Assignments Practice Location: 3911 Castlevale Rd, Ste 301, Yakima, WA 98902 Phone: 232-439-0776 |